Marc Ladanyi

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

203h-index206.2kcitations2.5kworks1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(1029), Cancer Genomics and Diagnostics(621), RNA modifications and cancer(360), Sarcoma Diagnosis and Treatment(357), Lung Cancer Research Studies(290)

Publications2.5k total

Pulmonary Solid and Granular Adenocarcinomas Expressing HepPar1: Highly Aggressive Tumors Exhibiting Mitochondrial Adaptation to STK11 Mutations rather than Hepatoid Differentiation
Modern Pathology·2026
Supplemental Table 1, Supplemental Table 2, Supplemental Table 3, Supplemental Table 6, Supplemental Table 7, Supplemental Figure 1, and Supplemental Figure 2 from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations
2025Open Access
Data from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations
2025Open Access
Supplemental Materials and Methods from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations
2025Open Access
Supplemental Table 5 from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations
2025Open Access
Supplemental Table 4 from Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations
2025Open Access
Publisher Correction: APOBEC3 mutagenesis drives therapy resistance in breast cancer
Nature Genetics·2025· 1 citedOpen Access
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification
Cancer Cell·2025· 3 citedOpen Access
Figure S2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
2025Open Access
Supplementary Figure 21 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Figure s2 from Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
2025Open Access
Supplementary Figure 22. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Figure 5 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
2025Open Access
Supplementary Figure 3 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplemental Figure 2 from Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in <i>EGFR</i>-Mutant Lung Adenocarcinomas
2025Open Access
Supplementary Figure S15 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
2025Open Access
Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
2025Open Access
Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure S4 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure S9 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
2025Open Access
page 1 of 123Next →

Frequent Co-authors

Ritika Kundra(15), Gregory J. Riely(14), Gad Getz(13), Debyani Chakravarty(13), Nikolaus Schultz(13), Maria E. Arcila(13), Ahmet Zehir(12), Michael F. Berger(12), David B. Solit(12), Mark G. Kris(12), Michael S. Lawrence(11), Vésteinn Thórsson(11), Walid K. Chatila(11), David M. Hyman(11), Thomas J. Giordano(10), Ilya Shmulevich(10), Zachary Heins(10), William Pao(10), Heidi J. Sofia(9), Sheila M. Reynolds(9)